Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1641 1645 1733
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18344790 | SURFACE DISPLAYED FUSION PROTEINS | Non-Final OA | Clara Foods Co. |
| 18696177 | ESCHERICHIA COLI HAVING 3-HYDROXYPROPIONATE PRODUCTION ABILITY, WITH 3-HYDROXYPROPIONATE PRODUCTION GENE INSERTED INTO SAME, AND USE THEREOF | Non-Final OA | LG CHEM, LTD. |
| 18701173 | COMPOSITION FOR PREVENTING, TREATING OR ALLEVIATING RHEUMATOID ARTHRITIS COMPRISING PROPIONIBACTERIUM FREUDENREICHII MJ2 STRAIN AS AN ACTIVE INGREDIENT | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18935074 | METHODS AND USES OF MICROBIOME COMPOSITIONS | Non-Final OA | MarvelBiome, Inc. |
| 18697325 | ENGINEERED VECTORS AND ORGANISMS CONTAINING THE SAME FOR ISOFLAVONE CONVERSION IN THE GUT | Non-Final OA | Board of Regents, The University of Texas System |
| 17434349 | TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM | Non-Final OA | The General Hospital Corporation |
| 18695708 | FISH REARING COMPOSITION, AND COMPOSITION FOR PREVENTING OR TREATING FISH DISEASES | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18293016 | MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS | Non-Final OA | EVONIK OPERATIONS GMBH |
| 18252124 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Non-Final OA | Pfizer Inc. |
| 17996109 | GENE MODIFIED FIBROBLASTS FOR THERAPEUTIC APPLICATIONS | Final Rejection | FIGENE, LLC |
| 18255275 | COMPOSITION FOR PREVENTING OR TREATING DETERIORATION IN BRAIN FUNCTION OR MAINTAINING OR IMPROVING BRAIN FUNCTION | Non-Final OA | TOKYO INSTITUTE OF TECHNOLOGY |
| 18549804 | COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT | Non-Final OA | KYOWA HAKKO BIO CO., LTD. |
| 18696076 | PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE PREVENTION OR TREATMENT OF VIRAL INFECTIONS | Non-Final OA | BIOCODEX |
| 18695879 | BIO-FUNGICIDES FORMULATIONS FOR INHIBITING PHYTOPHTHORA INFESTANS AND METHOD THEREOF | Non-Final OA | TAMIL NADU AGRICULTURAL UNIVERSITY |
| 18611899 | GASTRIC ACID-STABLE PROBIOTIC FORMULATUION AND THE PREAPATION METHOD THEREOF | Non-Final OA | VALVET CARE CO., LTD. |
| 18267687 | COMPOSITION FOR IMPROVING INFLAMMATION OF BRAIN TISSUE | Final Rejection | MEIJI CO., LTD. |
| 17906471 | T-CELL BISPECIFIC BINDING PROTEINS | Non-Final OA | CRISPR THERAPEUTICS AG |
| 18001498 | MODIFIED EXOTOXIN A PROTEINS | Non-Final OA | GlaxoSmithKline Biologicals SA |
| 18414311 | Albumin-Free Botulinum Toxin Formulations | Non-Final OA | REVANCE THERAPEUTICS, INC. |
| 17998194 | PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION | Non-Final OA | Research Development Foundation |
| 17672748 | PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18258950 | USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS | Non-Final OA | Fonterra Co-Operative Group Limited |
| 18368505 | VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | Non-Final OA | The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
| 18550036 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | Non-Final OA | HOUSTON METHODIST RESEARCH INSTITUTE |
| 18281265 | ANTIBACTERIAL METHODS & CELLS | Non-Final OA | Folium Food Science Limited |
| 18270659 | METHOD FOR SIMULTANEOUSLY DIAGNOSING ERWINIA CAROTOVORA AND PHYTOPHTHORA INFESTANS IN SOIL BY USING SEMI-QUANTITATIVE LATERAL FLOW IMMUNODIAGNOSTIC TECHNIQUE | Final Rejection | ABC CIRCLE CO., LTD. |
| 18267461 | APPLICATION OF BIFIDOBACTERIUM ANIMALIS IN IMPROVEMENT OF TUMOR IMMUNOTHERAPY RESPONSE | Non-Final OA | SHENZHEN JUNTUO BIOTECHNOLOGY CO., LTD |
| 17633386 | Composition for Babies and Infants for Improving Memory Ability in Childhood | Non-Final OA | MORINAGA MILK INDUSTRY CO., LTD. |
| 18251658 | THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE | Non-Final OA | Vaxinano |
| 18249030 | NOVEL TRYPANOSOMAL VACCINE | Non-Final OA | GENOME RESEARCH LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy